More companies that cut the contributions they made to employees’ 401(k) retirement plans earlier this year are reversing course as their businesses rebound and a Covid-19 vaccine is on the horizon.
Consider Quest Diagnostics Inc. The lab testing company suspended the matching contributions it made to its $4.59 billion 401(k) plan in April, as part of a cost-cutting initiative due to reductions in testing volumes.
But when patients returned to medical appointments this summer and Quest’s business recovered, it restarted those contributions on Aug. 23, four months sooner than planned.
“We reinstated to normalcy,” Chief Financial Officer Mark Guinan said on a recent call with Wall Street analysts.
Quest isn’t alone in restoring the status quo for employees.
